Combined treatment with SGLT2i and GLP1ra compared with SGLT2i or GLP1ra alone improves survival: a Real-World Registry

14 May 2024 (10:27 - 10:36)
Organised by: Logo
Congress Presentation Part of: Tailoring heart failure therapies on patient profiles Antidiabetic Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by